CYTOPOINT (lokivetmab)
Canine atopic dermatitis
About Zoetis
Zoetis operates as the leading global animal health company, spun off from Pfizer in 2013. The company focuses on discovering, developing, manufacturing, and commercializing animal health medicines, vaccines, and diagnostic products for both livestock and companion animals. With operations in more than 100 countries, Zoetis serves the critical need for animal protein production and pet health care globally.
View full company profileAbout Virbac SA
Virbac is a leading independent animal health company with a mission to improve the health and well-being of animals through innovative pharmaceutical solutions. Founded in 1968, it has grown into a global organization with a direct commercial presence in major markets and a diverse portfolio spanning pharmaceuticals, biologicals, and nutritional supplements. The company's strategy focuses on internal R&D, strategic acquisitions, and geographic expansion, particularly in emerging markets, to drive sustainable growth in the dynamic veterinary health sector.
View full company profileTherapeutic Areas
Other Canine atopic dermatitis Drugs
| Drug | Company | Phase |
|---|---|---|
| APOQUEL (oclacitinib) | Zoetis | Commercial |